137 related articles for article (PubMed ID: 2088475)
1. Rejection of MHC incompatible, Langerhans cell-free epidermal keratinocyte allografts in the rat.
Yeoman H; Munro AJ; Stanley MA
Reg Immunol; 1990; 3(2):75-81. PubMed ID: 2088475
[TBL] [Abstract][Full Text] [Related]
2. The influence of MHC-compatible and MHC-incompatible antigen-presenting cells on the survival of MHC-compatible cultured murine keratinocyte allografts.
Ramrakha PS; Sharp RJ; Yeoman H; Stanley MA
Transplantation; 1989 Oct; 48(4):676-80. PubMed ID: 2678636
[TBL] [Abstract][Full Text] [Related]
3. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response.
Cairns BA; deSerres S; Matsui M; Frelinger JA; Meyer AA
Transplantation; 1994 Jul; 58(1):67-72. PubMed ID: 8036710
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
Halliday GM; Odling KA; Muller HK
Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
[TBL] [Abstract][Full Text] [Related]
6. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
8. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
Rosenberg AS; Finbloom DS; Maniero TG; Van der Meide PH; Singer A
J Immunol; 1990 Jun; 144(12):4648-50. PubMed ID: 2112572
[TBL] [Abstract][Full Text] [Related]
9. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
10. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
11. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha.
Yeoman H; Anderton JG; Stanley MA
Immunology; 1989 Jan; 66(1):100-5. PubMed ID: 15493270
[TBL] [Abstract][Full Text] [Related]
12. Immunoelectron microscopic analysis of Ia antigen expression in rat skin during limb allograft rejection.
Mohtai M; Sugioka Y; Hotokebuchi T; Arai K; Hirana A; Wasano K; Kaibara N
Am J Pathol; 1990 Feb; 136(2):285-95. PubMed ID: 2154927
[TBL] [Abstract][Full Text] [Related]
13. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
14. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
15. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
[TBL] [Abstract][Full Text] [Related]
16. Cultured epithelium allografts: Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection.
Rouabhia M; Germain L; Bélanger F; Auger FA
Transplantation; 1993 Aug; 56(2):259-64. PubMed ID: 8102819
[TBL] [Abstract][Full Text] [Related]
17. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
[TBL] [Abstract][Full Text] [Related]
18. Survival of MHC-deficient mouse heterotopic cardiac allografts.
Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
[TBL] [Abstract][Full Text] [Related]
19. Quantitative differences in cell surface expression of class I MHC antigens on murine epidermal Langerhans cells.
Sharrow SO; Barden LA; Singer A; Katz SI
J Immunol; 1994 Jul; 153(1):110-6. PubMed ID: 8207229
[TBL] [Abstract][Full Text] [Related]
20. Cultured keratinocyte allografts fail to induce sensitization in vivo.
Cairns BA; deSerres S; Kilpatrick K; Frelinger JA; Meyer AA
Surgery; 1993 Aug; 114(2):416-22. PubMed ID: 8342143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
